What does a Kamala Harris Vice Presidency mean for cannabis legalisation?

Published 31-AUG-2020 14:22 P.M.

|

4 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Joe Biden announced that Kamala Harris is his pick for Vice President, should he win the upcoming US Presidential election in November. But what could a Biden/Harris ticket mean for cannabis legalisation?

The hints and suggestions throughout recent months that Kamala Harris would be selected as Biden's VP pick have today been confirmed, with the Presidential candidate stating: "I've decided that Kamala Harris is the best person to help me take this fight to Donald Trump and Mike Pence and then to lead this nation starting in January 2021."

The choice was somewhat expected following Biden's announcement that his VP selection would be a woman of colour, and Politico's accidental announcement that Biden's pick would indeed be Kamala Harris.

Now, as polls show Biden leading the race at 51% favourability compared with Trump's 41% among registered voters nationwide, according to the Monmouth University survey, it looks very possible that we will see a Biden and Kamala Presidency in 2021. Should this be the case, and Biden does take the mantle of Presidency in November, what does this mean for cannabis legalisation? Let's find out.

Kamala Harris's Cannabis Stance

As we've discussed previously, Joe Biden hasn't historically been an ally to cannabis advocates and has changed his stance on cannabis multiple times throughout his candidacy.

Biden famously resuscitated the 'gateway theory' argument about cannabis, highlighting his fears of legalising the plant, before releasing his 'Plan for Black America,' which seeks to decriminalise cannabis on a federal level if Biden wins the Presidency.

While this represents a positive progression from the perspective of cannabis legalization, Biden's views toward cannabis remain somewhat obstinate compared with his prior Democrat Presidential candidates like Bernie Sanders and Elizabeth Warren, who both vowed to federally legalise cannabis for recreational use in the US.

Similarly, Kamala Harris's lengthy public career as a lawyer, prosecutor, senator and the Attorney General of California have not given cannabis enthusiasts much to be excited about. In fact, one of the defining moments during Harris's Presidential bid in 2019 was when Tulsi Gabbard brought up Harris's career in law enforcement, saying:

"She put over 1,500 people in jail for marijuana violations, and then laughed about it when she was asked if she'd ever smoked marijuana. She blocked evidence that would have freed a man from death row until the courts forced her to do so. She kept people in prison beyond their sentences to use them as cheap labor for the state of California. And she fought to keep cash bail system in place that impacts poor people in the worst kind of way."

Many considered Gabbard's statements about Harris as the nail in the coffin for Kamala Harris's Presidential campaign, as Kamala's polling began to decline precipitously following Gabbards comments, and Kamala promptly pulled out of the race shortly thereafter.

Though Kamala has made attempts to distance herself from her harsh anti-cannabis history, having since become a cosponsor of the Marijuana Opportunity, Reinvestment, and Expungement Act (the MORE Act) which seeks to not only legalise cannabis and expunge cannabis-related crimes from records, but also to allocate additional funding to people of colour to mitigate the racially disparate impacts of the Drug War.

Will a Harris/Biden Win Result in Federal Cannabis Legalisation?

Joe Biden's pick for his VP was of particular relevance this year, given growing concerns about Biden's cognitive capacities, which have led to nearly 40% of voters believing that Biden is suffering from a mental decline. For this reason, predictions are arising suggesting that Biden's VP pick could very well automatically become the President at some point if Biden does indeed step down throughout his first term, with CNN Tweeting:

"Joe Biden made the pick that maximised his chances of continuing to make the race a straight referendum on Trump while also selecting someone whose resume suggests being ready to step in, if and when Biden decides to step aside."

If Biden secures the Presidency in November and "steps aside" sooner rather than later, we may see a transition into a Kamala Harris Presidency, either in an explicit or "de facto" sense over the next few years.

Though whether she's VP or the President of the US, Harris's recent support of the MORE Act indicates that some positive change will likely occur within the industry should Biden win the Presidency. Moreover, decriminalising or federally legalizing cannabis would be a good method for Kamala Harris to distance herself from Tulsi Gabbard's comments last year, which painted Harris as a staunch, anti-drug legislator.

With current polls showing Biden to be the favourite in the upcoming election, it remains to be seen what impact his choice of Kamala Harris as his VP will have on his favourability moving forward.

Originally published on The Green Fund.

Louis O'Neill is a writer based in Sydney with a focus on social and political issues. Having interviewed local politicians and entrepreneurs, Louis now focuses on cannabis culture, legislation & reform.

The Green Fund is Asia Pacific's preeminent media house positioned at the forefront of the global cannabis industry. Committed to driving the industry forward, we spotlight the sector from all angles, explore the companies and the players making headlines, and cover some of the biggest cannabis companies in the world.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X